Trial Profile
Single-Blinded, Randomized Assessment of Post-Mastectomy Analgesia Using Exparel (Liposomal) Versus Standard Bupivacaine or Placebo
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Jul 2022
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Adverse reactions; Therapeutic Use
- 21 Aug 2019 Status changed from not yet recruiting to recruiting.
- 06 Feb 2019 Planned End Date changed from 1 Dec 2020 to 1 Dec 2021.
- 06 Feb 2019 Planned primary completion date changed from 1 Dec 2019 to 1 Dec 2020.